Related Experiment Videos
Inhibition of Lyn function in mast cell activation by SH3 domain binding peptides
T P Stauffer1, C H Martenson, J E Rider
1Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, 27710, USA.
Abstract:
While Lyn tyrosine kinase has been shown to be necessary for IgE-receptor (FcepsilonRI)-mediated mast cell activation, the mechanism of Lyn activation is not yet understood. Using a micro-electroporation technique to quantitatively introduce peptides into the cytosol of tumor mast cells, we show that proline-rich peptides that preferentially bind Src family SH3 domains block receptor-induced repetitive calcium spikes in a concentration dependent manner. The Src family member Lyn was the likely target, since a series of phage displaying derived peptides with increased Lyn SH3 domain binding specificity inhibited FcepsilonRI-mediated calcium signaling at concentrations consistent with binding to Lyn rather than other Src-type kinases. Furthermore, SH3 binding peptides prevented the plasma membrane translocation of a fluorescently labeled Syk tandem SH2 domain, which binds to phosphorylated FcepsilonRI, suggesting that the peptides specifically block the Lyn-mediated step by which FcepsilonRI cross-linking leads to receptor phosphorylation. Our study suggests that the binding of proline-rich peptides, or corresponding cellular interaction partners, to Lyn SH3 domain suppresses the Lyn-mediated phosphorylatation of FcepsilonRI and calcium signaling.
Insights
Proline-rich peptides targeting the Lyn SH3 domain block IgE receptor-mediated mast cell activation by inhibiting FcepsilonRI phosphorylation and calcium signaling.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Lyn tyrosine kinase is crucial for IgE receptor (FcepsilonRI)-mediated mast cell activation.
- The precise mechanism of Lyn activation remains unclear.
Purpose of the Study:
- To investigate the mechanism of Lyn activation in mast cells.
- To identify specific molecular interactions that regulate FcepsilonRI signaling.
Main Methods:
- Utilized micro-electroporation to introduce peptides into mast cells.
- Employed phage display to derive peptides with specific binding to Lyn SH3 domains.
- Monitored calcium signaling and Syk translocation in response to FcepsilonRI stimulation.
Main Results:
- Proline-rich peptides binding to Src family SH3 domains inhibited calcium spikes in a dose-dependent manner.
- Peptides with enhanced Lyn SH3 specificity blocked FcepsilonRI-mediated calcium signaling at relevant concentrations.
- SH3 binding peptides prevented Syk translocation, indicating a block in FcepsilonRI phosphorylation.
Conclusions:
- Peptide binding to the Lyn SH3 domain suppresses Lyn-mediated FcepsilonRI phosphorylation.
- This suppression inhibits downstream calcium signaling in mast cells.
- Identified a potential therapeutic target for modulating mast cell activation.